Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
- PMID: 39235512
- PMCID: PMC11775047
- DOI: 10.1007/s00213-024-06680-z
Multimodal creativity assessments following acute and sustained microdosing of lysergic acid diethylamide
Abstract
Introduction: Enhanced creativity is often cited as an effect of microdosing (taking repeated low doses of a psychedelic drug). There have been recent efforts to validate the reported effects of microdosing, however creativity remains a difficult construct to quantify.
Objectives: The current study aimed to assess microdosing's effects on creativity using a multimodal battery of tests as part of a randomised controlled trial of microdosing lysergic acid diethylamide (LSD).
Methods: Eighty healthy adult males were given 10 µg doses of LSD or placebo every third day for six weeks (14 total doses). Creativity tasks were administered at a drug-free baseline session, at a first dosing session during the acute phase of the drug's effects, and in a drug-free final session following the six-week microdosing regimen. Creativity tasks were the Alternate Uses Test (AUT), Remote Associates Task (RAT), Consensual Assessment Technique (CAT), and an Everyday Problem-Solving Questionnaire (EPSQ).
Results: No effect of drug by time was found on the AUT, RAT, CAT, or EPSQ. Baseline vocabulary skill had a significant effect on AUT and RAT scores.
Conclusions: Despite participants reporting feeling more creative on dose days, objective measurement found no acute or durable effects of the microdosing protocol on creativity. Possible explanations of these null findings are that laboratory testing conditions may negatively affect ability to detect naturalistic differences in creative performance, the tests available do not capture the facets of creativity that are anecdotally affected by microdosing, or that reported enhancements of creativity are placebo effects.
Keywords: Convergent thinking; Creativity; Lysergic acid diethylamide; Microdosing divergent thinking; Psychedelics.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Competing interests: This research was conducted with funding from the Health Research Council of New Zealand (Grant No. 20/845 [to SM and RLS]), MindBio Therapeutics Ltd, and three private donors. SM, and RLS have received research funding from MindBio Therapeutics Ltd. to conduct further work in psychedelic microdosing. RJM has received conference support from MindBio Therapeutics Ltd. SM has received funding from atai Life Sciences for unrelated research work.
Figures




Similar articles
-
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting.Psychopharmacology (Berl). 2018 Dec;235(12):3401-3413. doi: 10.1007/s00213-018-5049-7. Epub 2018 Oct 25. Psychopharmacology (Berl). 2018. PMID: 30357434 Free PMC article. Clinical Trial.
-
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.J Psychopharmacol. 2022 Jan;36(1):85-96. doi: 10.1177/0269881120953994. Epub 2020 Oct 8. J Psychopharmacol. 2022. PMID: 33591231
-
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.Trials. 2024 Aug 24;25(1):560. doi: 10.1186/s13063-024-08384-3. Trials. 2024. PMID: 39182140 Free PMC article.
-
Microdosing Psychedelics: Current Evidence From Controlled Studies.Biol Psychiatry Cogn Neurosci Neuroimaging. 2024 May;9(5):500-511. doi: 10.1016/j.bpsc.2024.01.002. Epub 2024 Jan 26. Biol Psychiatry Cogn Neurosci Neuroimaging. 2024. PMID: 38280630 Review.
-
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.J Psychopharmacol. 2024 Aug;38(8):701-711. doi: 10.1177/02698811241254831. Epub 2024 Jun 14. J Psychopharmacol. 2024. PMID: 38877715 Free PMC article. Review.
Cited by
-
Early detection of cognitive decline with deep learning and graph-based modeling.MethodsX. 2025 Jun 2;14:103405. doi: 10.1016/j.mex.2025.103405. eCollection 2025 Jun. MethodsX. 2025. PMID: 40567946 Free PMC article.
References
-
- Amabile T (1996) Creativity in context. Westview
-
- Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L-A, Hui K, Farb N (2019b) Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Psychopharmacology 236(2):731–740. 10.1007/s00213-018-5106-2 - PubMed
-
- Baggott MJ (2015) Psychedelics and creativity: A review of the quantitative literature. PeerJ PrePrints, 3: e1202v1. 10.7287/peerj.preprints.1202v1
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous